Note: This study is about Zepbound (tirzepatide), not Foundayo (orforglipron)

[17] [18] Evidence-based strategies to optimise long-term effectiveness include: Regular dose review : Working with healthcare providers to ensure patients are on an appropriate therapeutic dose, with consideration for dose escalation if weight loss plateaus and the medication is well-tolerated Structured lifestyle support : Engaging with dietitians, physiotherapists, or NHS weight management programmes to reinforce behavioural changes and prevent gradual increases in caloric intake Monitoring and accountability : Regular follow-up appointments to track weight, metabolic parameters, and treatment adherence, as recommended in NICE guidelines for obesity management Addressing side effects proactively : Managing gastrointestinal symptoms or other adverse effects to improve adherence and prevent treatment discontinuation It's important to note that current evidence and clinical guidelines do not support the use of "medication holidays" or cycling of GLP-1 treatments
:max_bytes(150000):strip_icc()/Health-GettyImages-1033197734-1241091e7689444198b734964c7a13bb.jpg)
This diabetes medication can treat obesity, but its not for people who just want to drop a few pounds Image content: This image is available to view online
We also discuss the causes and treatments for common skin conditions, including dandruff, acne, rosacea, eczema, psoriasis, and vitiligo
Although air bubbles are a major problem if they reach the bottom of the centrifuge tube (low density first delivery), they are no less a problem for high-density first delivery as they interfere with the smooth flow of liquid down the tube wall